AG
MRNA icon

Advisor Group’s Moderna MRNA Stock Holding History

Advisor Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.08M Buy
55,207
+49,207
+820% +$873K 0.01% 1143
2019
Q3 		$96K Buy
6,000
+5,003
+502% +$73.9K ﹤0.01% 2911
2019
Q2 		$15K Buy
997
+72
+8% +$1.55K ﹤0.01% 4146
2019
Q1 		$19K Buy
925
+625
+208% +$11.6K ﹤0.01% 4013
2018
Q4 		$5K Buy
+300
New +$4.93K ﹤0.01% 4521

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return

Advisor Group's MRNA Position: Q4 2019 in Review

Advisor Group increased its Moderna (MRNA) stake by 820% in Q4 2019, buying an estimated $873K and bringing the position to 55,207 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #1143.

Advisor Group first reported a position in MRNA in Q4 2018 and has held it in 5 quarters since. 159 funds tracked by Wall St. Rank hold MRNA as of Q4 2019.

  • Advisor Group held 55,207 shares of Moderna worth $1.08M as of Q4 2019.
  • Advisor Group bought 49,207 Moderna shares in Q4 2019, an estimated $873K.
  • Moderna made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1143 holding.
  • Advisor Group first reported a position in Moderna in Q4 2018 and has held it in 5 quarters since.
  • 159 funds tracked by Wall St. Rank held Moderna as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.